⌘K

Home/Filings/4/0000899243-17-019222

4//SEC Filing

Aivado Manuel 4

Accession 0000899243-17-019222

CIK 0001420565other

View on SEC.gov Company Profile

Filed

Jul 26, 8:00 PM ET

Accepted

Jul 27, 6:36 PM ET

Size

5.4 KB

Accession

0000899243-17-019222

Insider Transaction Report

Form 4

Period: 2017-07-25

AILERON THERAPEUTICS INCALRN

Director

Transactions

Award
Stock Option (right to buy)
2017-07-25+57,388→ 57,388 total
Exercise: $13.00Exp: 2027-07-24→ Common Stock (57,388 underlying)

Footnotes (1)

[F1]This option was granted on July 25, 2017. The shares underlying the option are scheduled to vest in equal monthly installments over four years from July 25, 2017.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

AILERON THERAPEUTICS INC

CIK 0001420565

Entity typeother

Related Parties

1

filerCIK 0001709603

Filing Metadata

Form type: 4
Filed: Jul 26, 8:00 PM ET
Accepted: Jul 27, 6:36 PM ET
Size: 5.4 KB

View on SEC.gov